Stroke following transcatheter aortic valve implantation. Is neuroprotection justified?

Postepy w Kardiologii Interwencyjnej

Volumn 9, Issue 4, 2013, Pages 376-382

  Dab̧rowski, Maciej ^a   Witkowski, Adam ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Neuroprotection; Stroke; Transcatheter aortic valve implantation

Indexed keywords

NITINOL;

AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BRACHIOCEPHALIC TRUNK; BRAIN CALCIFICATION; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; EMBOLIC PROTECTION DEVICE; HEART ATRIUM FIBRILLATION; HEART VALVE BIOPROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; NEUROPROTECTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; VERY ELDERLY;

EID: 84890962341     PISSN: 17349338     EISSN: 18974295     Source Type: Journal    
DOI: 10.5114/pwki.2013.38868     Document Type: Article

References (40)

1. Vahanian A, Baumgartner H, Bax J. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
2. Schwarz F, Baumann P, Manthey J. The effect of aortic valve replacement on survival. Circulation 1982; 66: 1105-1110.
3. Ross JJ, Braunwald E. Aortic stenosis. Circulation 1968; 38 (Suppl.): 61-67.
4. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26: 2714-2720.
5. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular disease. Eur Heart J 2003; 24: 1231-1243.
6. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008.
7. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703.
8. Leon MB, Smith CR, Mack M, et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
9. Smith CR, Leon MB, Mack MJ, et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
10. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the corevalve revalving system. Circ Cardiovasc Inter 2008; 1: 167-175.
11. Kodali SK, Williams MR, Smith CR, et al.; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695.
12. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Eurointervention 2008; 4: 242-249.
13. Tay EL, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2011; 4: 1290-1297.
14. Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg 2011; 40: 475-479.
15. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121: 870-878.
16. Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010; 55: 1427-1432.
17. Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011; 57: 18-28.
18. Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv 2010; 3: 1126-1132.
19. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012; 98: 18-23.
20. Van Mieghem NM, Serruys PW. Embolic protection devices during TAVI - the "proof of the pudding". EuroIntervention 2012; 8: 25-29.
21. Russell D. Cerebral microemboli and cognitive impairment. J Neurol Sci 2002; 203-204: 211-214.
22. Mosley THJ, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005; 64: 2056-2062.
23. Vermeer SE, Longstreth WTJ, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6: 611-619.
24. Duffis EJ, Jones D, Tighe D, et al. Neurological complications of coronary angiographic procedures. Expert Rev Cardiovasc Ther 2007; 5: 1113-1121.
25. Drews T, Pasic M, Buz S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg 2011; 59: 237-242.
26. Szeto WY, Augoustides JG, Desai ND, et al. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg 2011; 26: 348-354.
27. Reinsfelt B, Westerlind A, Ioanes D, et al. Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol Scand 2012; 56: 240-247.
28. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 1637-1643.
29. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012; 126: 3041-3053.
30. Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012; 8: 129-138.
31. Etienne PY, Papadatos S, Pieters D, et al. Embol-x intraaortic filter and transaortic approach for improved cerebral protection in transcatheter aortic valve implantation. Ann Thorac Surg 2011; 92: e95-e96.
32. Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010; 3: 1133-1138.
33. Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 2012; 8: 43-50.
34. Onsea K, Agostoni P, Samim M, et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 2012; 8: 51-56.
35. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-invalve implantation for failed bioprosthetic heart valves. Circulation 2010; 121: 1848-1857.
36. Pasic M, Unbehaun A, Dreysse S, et al. Transapical aortic valve implantation after previous aortic valve replacement: clinical proof of the "valve-in-valve" concept. J Thorac Cardiovasc Surg 2011; 142: 270-277.
37. Seiffert M, Franzen O, Conradi L, et al. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv 2010; 76: 608-615.
38. Kempfert J, Van Linden A, Linke A, et al. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg 2010; 89: 1934-1941.
39. Ferrari E. Transapical aortic 'valve-in-valve' procedure for degenerated stented bioprosthesis. Eur J Cardiothorac Surg 2012; 41: 485-490.
40. Macdonald S. New embolic protection devices: a review. J Cardiovasc Surg (Torino) 2011; 52: 821-827.